Stefanou Amalia, Marshall Nathan, Holdan Wendy, Siddiqui Aamir
Department of Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.
J Hand Surg Am. 2012 Jan;37(1):104-9. doi: 10.1016/j.jhsa.2011.10.005.
We designed a prospective, randomized study to evaluate the effects of iontophoresis delivery of dexamethasone versus corticosteroid injection therapy on patient outcomes.
We randomized 82 patients to 10 mg dexamethasone via iontophoresis using a self-contained patch with a 24-hour battery; 10 mg dexamethasone injection; or 10 mg triamcinolone injection. All patients received the same hand therapy protocol. Primary outcomes tracked were change in grip strength (flexion vs extension), pain, and function scores on a validated questionnaire. The secondary outcome was return-to-work status. Patients were evaluated at baseline, completion of physical therapy, and 6-month follow-up.
The iontophoresis patients had statistically significant improvement in grip strength at the conclusion of hand therapy compared with baseline. They were also more likely to get back to work without restriction. By 6-month follow-up, all groups had equivalent results for all measured outcomes.
Dexamethasone via iontophoresis produced short-term benefits because for this group grip strength and unrestricted return to work were significantly better. This study suggests that this iontophoresis technique for delivery of corticosteroid may be considered a treatment option for patients with lateral epicondylitis.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic II.
我们设计了一项前瞻性随机研究,以评估地塞米松离子导入疗法与皮质类固醇注射疗法对患者治疗效果的影响。
我们将82例患者随机分为三组,分别接受使用含24小时电池的独立贴片进行离子导入给予10毫克地塞米松、注射10毫克地塞米松或注射10毫克曲安奈德治疗。所有患者均接受相同的手部治疗方案。追踪的主要结局指标为握力变化(屈曲与伸展)、疼痛以及一份有效问卷上的功能评分。次要结局指标为复工状态。在基线、物理治疗结束时以及6个月随访时对患者进行评估。
与基线相比,离子导入治疗的患者在手部治疗结束时握力有统计学意义的改善。他们也更有可能不受限制地恢复工作。到6个月随访时,所有组在所有测量结局指标上的结果相当。
通过离子导入给予地塞米松产生了短期益处,因为该组的握力和不受限制地恢复工作情况明显更好。本研究表明,这种用于递送皮质类固醇的离子导入技术可被视为外侧上髁炎患者的一种治疗选择。
研究类型/证据水平:治疗性II级。